Discover DOPTELET® (avatrombopag), a medication used to increase low blood platelet counts in adults with chronic immune thrombocytopenia (ITP).
The Observation of Clinical Efficacy of Different Doses of Rituximab in Treatment of Chronic ITP免疫性血小板减少症利妥昔单抗临床疗效目的:探讨不同剂量利妥昔单抗治疗慢性免疫性血小板减少症(ITP)的临床疗效、安全性。方法:选取笔者所在科室2011年7月-2013年7月慢性免疫性血小板减少症患者44例,采取随机...
Learn more about DOPTELET® (avatrombopag) for your patients, indicated for adults with chronic Immune Thrombocytopenia (ITP) or Chronic Liver Disease (CLD)
This paper presents a summary of the evidence review group (ERG) report into the clinical effectiveness and cost-effectiveness of eltrombopag for the treatment of adults with chronic idiopathic (immune) thrombocytopenic purpura (ITP), based on a review of the manufacturer's submission (MS) to the...
Coffee acid film treatment of chronic hard-to-cure sexual ITP clinical research 翻译结果5复制译文编辑译文朗读译文返回顶部 Coffeic acid piece treatment chronicity difficult ITP clinical research 相关内容 ago one's separate ways 是一.的分开的方式[translate] ...
Two of them showed a prominent increase in the platelet count and therapy was eventually stopped. This therapeutic approach may have an important role in treatment of childhood ITP, refractory to the conventional therapy.关键词: 1g/kg/day
Based on this dataset, VNN1 is the only gene that was detected to be overexpressed in both patients with progression to chronic ITP and patients with treatment-resistant chronic ITP. Next, we used quantitative real-time PCR to measure VNN1 expression in the original 3 patient groups (self-...
/l with at least a 2-fold increase from baseline according to international definitions. 12 patients who required any other treatment for itp including rescue therapy more than 6 weeks after inclusion were considered non-responders regardless of the platelet count. secondary endpoints secondary ...
10 Two thrombopoietin-receptor agonists (TPO-RAs), eltrombopag and romiplostim, have been approved for the second-line treatment of chronic ITP. Both are effective in treating chronic ITP but have practical limitations; currently, in the United States, romiplostim must be given subcutaneously by a ...
Corticosteroids have been the first line of treatment of ITP since 1950, however some patients do not respond to this treatment (refractory) and some will relapse after its discontinuation. For such patients second line treatments were introduced. Some patients will continue to be refractory to this...